Anne Marie Falk

Array ( [id] => 8642423 [patent_doc_number] => 08367406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Pluripotent cells' [patent_app_type] => utility [patent_app_number] => 12/506128 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 10420 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12506128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642423 [patent_doc_number] => 08367406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Pluripotent cells' [patent_app_type] => utility [patent_app_number] => 12/506128 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 10420 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12506128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367846 [patent_doc_number] => 20090305405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'USE OF TGF BETA SUPERFAMILY ANTAGONISTS AND NEUROTROPHINS TO MAKE NEURONS FROM EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/500998 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19059 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305405.pdf [firstpage_image] =>[orig_patent_app_number] => 12500998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575144 [patent_doc_number] => 07829757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'SGRF gene-modified mouse' [patent_app_type] => utility [patent_app_number] => 12/499694 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10165 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829757.pdf [firstpage_image] =>[orig_patent_app_number] => 12499694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252289 [patent_doc_number] => 20100028398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS' [patent_app_type] => utility [patent_app_number] => 12/498887 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11108 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028398.pdf [firstpage_image] =>[orig_patent_app_number] => 12498887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943780 [patent_doc_number] => 08496956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Implantable nerve regeneration conduit' [patent_app_type] => utility [patent_app_number] => 12/492058 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7433 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12492058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495807 [patent_doc_number] => 20090263835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/487869 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28827 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263835.pdf [firstpage_image] =>[orig_patent_app_number] => 12487869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490424 [patent_doc_number] => 20090291495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Neural Cell Populations from Primate Pluripotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/477726 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19056 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291495.pdf [firstpage_image] =>[orig_patent_app_number] => 12477726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427050 [patent_doc_number] => 08703120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Use of oncolytic herpes viruses for killing cancer stem cells' [patent_app_type] => utility [patent_app_number] => 12/994960 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 45 [patent_no_of_words] => 21633 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485366 [patent_doc_number] => 20090275131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHOD FOR PRODUCTION OF MAST CELLS FROM STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/435123 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14283 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275131.pdf [firstpage_image] =>[orig_patent_app_number] => 12435123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6198313 [patent_doc_number] => 20110030071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Transgenic Animal Model of Cancer and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/811066 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7284 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20110030071.pdf [firstpage_image] =>[orig_patent_app_number] => 12811066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496478 [patent_doc_number] => 20090264506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/419999 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264506.pdf [firstpage_image] =>[orig_patent_app_number] => 12419999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6333900 [patent_doc_number] => 20100115635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Methods for Assessing the Delivery of Exogenous Agents' [patent_app_type] => utility [patent_app_number] => 12/415610 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8622 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20100115635.pdf [firstpage_image] =>[orig_patent_app_number] => 12415610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5459939 [patent_doc_number] => 20090260091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Methods and animal model for analyzing age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 12/382702 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9252 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20090260091.pdf [firstpage_image] =>[orig_patent_app_number] => 12382702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342414 [patent_doc_number] => 20090181064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'XENOTRANSPLANT FOR CNS THERAPY' [patent_app_type] => utility [patent_app_number] => 12/398642 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6152 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181064.pdf [firstpage_image] =>[orig_patent_app_number] => 12398642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533041 [patent_doc_number] => 20090232829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/389193 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 29601 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232829.pdf [firstpage_image] =>[orig_patent_app_number] => 12389193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273700 [patent_doc_number] => 20100299767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TREM-2 GENE AND PROTEIN AS INHIBITORS OF EXPRESSION OF GA733-2, AND TRANSGENIC ANIMALS COMPRISING THE SAME AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/863548 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5307 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20100299767.pdf [firstpage_image] =>[orig_patent_app_number] => 12863548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478637 [patent_doc_number] => 20100092430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES' [patent_app_type] => utility [patent_app_number] => 12/361201 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14631 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092430.pdf [firstpage_image] =>[orig_patent_app_number] => 12361201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479649 [patent_doc_number] => 20090202606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor' [patent_app_type] => utility [patent_app_number] => 12/359137 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22972 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202606.pdf [firstpage_image] =>[orig_patent_app_number] => 12359137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264361 [patent_doc_number] => 20090117046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'METHODS FOR EVALUATING GENETIC SUSCEPTIBILITY AND THERAPY FOR CHRONIC INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/352460 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117046.pdf [firstpage_image] =>[orig_patent_app_number] => 12352460 [rel_patent_id] =>[rel_patent_doc_number] =>)